News | Ultrasound Women's Health | October 26, 2018

Philips Debuts Integrated Breast Ultrasound Solution

First dedicated Philips ultrasound solution for breast assessment, combining advanced imaging, full solution elastography, screening and precision biopsy

Philips Debuts Integrated Breast Ultrasound Solution

October 26, 2018 — Philips announced what it calls its ultimate ultrasound solution for breast assessment, available with the Philips Epiq and Affiniti ultrasound systems, and the combination of the eL18-4 transducer and anatomical intelligence. This all-in-one solution brings together high-quality imaging with complementary clinical tools tailored for breast screenings. With the new breast solution, clinicians can efficiently assess, monitor and treat breast diseases, increasing diagnostic confidence and helping to improve patient care.

The Philips ultimate ultrasound solution for breast assessment is CE marked and has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Many clinicians depend on ultrasound to enhance detection of breast cancers, especially in women with dense breast tissue, which is unrelated to weight or breast size. According to a report published by the Journal of the US National Cancer Institute, an estimated 43.3 percent of women between the ages of 40 and 74 years old have extremely dense breast tissue [1].

With X-ray mammography, dense breast tissue can sometimes mask small cancerous lesions. Clinicians often rely on ultrasound as a follow-up diagnostic test in cases where lesions are suspected. Developed in partnership with clinicians around the world, the Philips ultimate ultrasound solution for breast assessment empowers clinicians to detect breast lesions with confidence and allows them to do so in an intuitive, efficient way. Together, this solution enhances the patient experience by reducing total exam time, eliminating the need for inconvenient room or equipment changes, and avoiding multiple appointments which can result in additional anxiety for patients awaiting diagnosis.

“The best way to increase the survival rate from breast cancer is to detect it early,” said Marcela Böhm-Vélez, M.D., Weinstein Imaging Associates, Pittsburgh. “For women with dense breasts, ultrasound can be very helpful in detecting masses not easily seen on the mammogram. I have been impressed by Philips’ continued investment and innovation in developing breast assessment solutions, so that I can provide optimal care for my patients.”

Philips’ integrated breast solution combines four features that work together for comprehensive and confident screening and diagnosis. The PureWave eL18-4 ultra-broadband linear array transducer is a single transducer that delivers high-quality imaging for patients, including those who may be more technically challenging to image. PureWave crystal technology delivers fine-elevation focusing to provide exceptional detail resolution and tissue uniformity, as well as extended depth of field performance.

Anatomical intelligence for breast enhances reproducibility and streamlines workflow while preserving image quality during the breast exam. The automation and intelligence provides visual mapping and annotation of screened anatomy, with minimal user interaction, to give clinicians confidence while documenting full coverage of the breast during the acquisition phase.

Full solution elastography ElastQ Imaging shear wave and strain elastography allows clinicians to rapidly assess a wide array of breast lesions with elevated diagnostic confidence. In combining both wave methods, ElastQ Imaging reveals more definitive information on tissue stiffness in the breast.

A new precision biopsy allows physicians to enhance the patient experience by performing more targeted biopsies. Reduced blind zones and enhanced needle reflections elevate clinical during interventional procedures.

For more information: www.usa.philips.com/healthcare

 

Reference

[1] Brian L. Sprague, Ronald E. Gangnon, Veronica Burt, Amy Trentham-Dietz, John M. Hampton, Robert D. Wellman, Karla Kerlikowske, Diana L. Miglioretti; Prevalence of Mammographically Dense Breasts in the United States, JNCI: Journal of the National Cancer Institute, Volume 106, Issue 10, 1 October 2014, dju255, https://doi.org/10.1093/jnci/dju255

 

Related Content

#SiemensHealthineers #Varian #Siemens The transformative combination accelerates the company’s impact on #global #healthcare and establishes a strong partner for #customers and #patients along the entire #cancer care continuum and for many of the most threatening #diseases
News | Radiology Business | April 15, 2021
April 15, 2021 — Siemens Healthineers AG an
Comparisons of high definition and standard definition infrared imaging for digital histopathology. Image courtesy of the Beckman Institute

Comparisons of high definition and standard definition infrared imaging for digital histopathology. Image courtesy of the Beckman Institute

News | Breast Imaging | April 14, 2021
April 14, 2021 — Detecting and analyzing breast cancer
3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine screenings, when compared with traditional mammography, according to a large study from Lund University in Sweden. The results are published in the journal Radiology.

Getty Images

News | Breast Imaging | April 09, 2021
April 9, 2021 — 3-D mammography reduces the number of breast cancer cases diagnosed in the period between routine scr
Mobidiag Oy, a privately held, commercial-stage Finnish-French developer of innovative molecular diagnostic tests and instrumentation, announced today that it has signed a definitive agreement to be acquired by Hologic, Inc., a global leader in women's health, for an enterprise value of approximately $795 million.  This includes a cash payment of approximately $714 million for Mobidiag’s equity, and net debt of approximately $81 million.
News | Women's Health | April 08, 2021
April 8, 2021 — Mobidiag Oy, a privately held, commercial-stage F
Axial chest CT examination in a 54-year-old participant. A, On the axial noncontrast chest CT image, the pectoralis muscle (PM) area was segmented and measured in the section above the aortic arch. B, The subcutaneous adipose tissue (SAT) area as the area between the PM and the skin surface on the same section was also measured and the attenuation of pixels in the SAT area was used to determine the individualized threshold for the intermuscular adipose tissue (IMAT). C, The IMAT within the PM was segmented

Axial chest CT examination in a 54-year-old participant. A, On the axial noncontrast chest CT image, the pectoralis muscle (PM) area was segmented and measured in the section above the aortic arch. B, The subcutaneous adipose tissue (SAT) area as the area between the PM and the skin surface on the same section was also measured and the attenuation of pixels in the SAT area was used to determine the individualized threshold for the intermuscular adipose tissue (IMAT). C, The IMAT within the PM was segmented as the areas with Hounsfield units below this threshold for the IMAT (arrowheads). Image courtesy of the Radiological Society of North America

News | Computed Tomography (CT) | April 07, 2021
April 7, 2021 — Body composition information derived from routine chest...
Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

Ultrasound is an invaluable diagnostic tool for the early detection of breast cancer, but the classification of lesions is sometimes challenging and time consuming. Could artificial intelligence hold the answer to solving these problems? Graphic courtesy of Chinese Medical Journal

News | Artificial Intelligence | April 06, 2021
April 6, 2021 — In 2020, the International Agency for Research on...
Videos | Point-of-Care Ultrasound (POCUS) | April 01, 2021
Here are two quick clinical examples of point-of-care ultrasound (POCUS) lung imaging and cardiac imaging using a GE
While the COVID-19 crisis is challenging, the pandemic is also giving researchers an opportunity to discover new approaches to saving lives. A study published in the JAMA Network Open on Thursday, March 25, 2021, recommends a new way for triaging mammogram patients during times of limited capacity, such as pandemic surges, when individuals may also experience anxiety about COVID-19.

Getty Images

News | Breast Imaging | April 01, 2021
April 1, 2021 — While the COVID-19 crisis is challenging, the pandemic is also giving researchers an opportunity to d